|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 05-20 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-16 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 5.34M 4.61M 4.33M 3.94M 7.41M 511M 7.51M 50.73M 19.88M 256M 20.06M 19.63M 851M | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 7.49M 6.47M 6.07M 5.52M 10.39M 716M 10.53M 71.1M 27.86M 359M 28.12M 27.51M 1.19B | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 08/03/2024 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 01/01/2012 |
William Resides
BRD | Director/Board Member | 57 | 08/03/2024 |
Suzanne Bird
BRD | Director/Board Member | 61 | 08/03/2024 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.34M 2.02M 1.9M 1.73M 3.25M 224M 3.29M 22.22M 8.71M 112M 8.79M 8.6M 373M | 1.85M 1.6M 1.5M 1.37M 2.57M 177M 2.61M 17.61M 6.9M 88.84M 6.96M 6.81M 296M |
| Net income | -23.05M -19.9M -18.67M -17.01M -31.98M -2.2B -32.42M -219M -85.77M -1.1B -86.55M -84.68M -3.67B | -1.54M -1.33M -1.25M -1.14M -2.14M -148M -2.17M -14.66M -5.74M -73.94M -5.8M -5.67M -246M |
| Net Debt | 2.11M 1.82M 1.71M 1.55M 2.92M 201M 2.96M 19.99M 7.83M 101M 7.91M 7.74M 336M | 2.15M 1.85M 1.74M 1.58M 2.98M 205M 3.02M 20.37M 7.98M 103M 8.05M 7.88M 342M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















